Multi-site-specific isotopic labeling accelerates high-resolution structural investigations of pathogenic huntingtin exon-1

Structure. 2023 Jun 1;31(6):644-650.e5. doi: 10.1016/j.str.2023.04.003. Epub 2023 Apr 28.

Abstract

Huntington's disease neurodegeneration occurs when the number of consecutive glutamines in the huntingtin exon-1 (HTTExon1) exceeds a pathological threshold of 35. The sequence homogeneity of HTTExon1 reduces the signal dispersion in NMR spectra, hampering its structural characterization. By simultaneously introducing three isotopically labeled glutamines in a site-specific manner in multiple concatenated samples, 18 glutamines of a pathogenic HTTExon1 with 36 glutamines were unambiguously assigned. Chemical shift analyses indicate the α-helical persistence in the homorepeat and the absence of an emerging toxic conformation around the pathological threshold. Using the same type of samples, the recognition mechanism of Hsc70 molecular chaperone has been investigated, indicating that it binds to the N17 region of HTTExon1, inducing the partial unfolding of the poly-Q. The proposed strategy facilitates high-resolution structural and functional studies in low-complexity regions.

Keywords: Huntington’s disease; conformational ensemble; huntingtin; intrinsically disordered proteins; isotopic labeling; nuclear magnetic resonance; poly-Q; tRNA suppression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Exons
  • Huntingtin Protein / chemistry
  • Magnetic Resonance Spectroscopy
  • Peptides* / chemistry
  • Protein Conformation, alpha-Helical

Substances

  • Peptides
  • Huntingtin Protein